Previous Article | Next Article 
Journal of Clinical Microbiology, January 1998, p. 311-314, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Absolute Copy Number and Relative Change in Determinations of
Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an
External Standard on Kit Comparisons
Donald
Brambilla,1
Sheila
Leung,1
Judy
Lew,2
John
Todd,3
Steven
Herman,4
Mike
Cronin,5
David E.
Shapiro,6
James
Bremer,7
Celine
Hanson,8
George V.
Hillyer,9
George D.
McSherry,10
Rhoda S.
Sperling,11
Robert W.
Coombs,12 and
Patricia S.
Reichelderfer2,*
New England Research Institutes, Watertown,
Massachusetts 021721;
National Institute
of Allergy and Infectious Diseases, Bethesda, Maryland
208922;
Chiron Corporation, Emeryville,
California 946083;
Roche Molecular
Systems, Branchburg, New Jersey 088764;
Organon Teknika Corporation, Durham, North Carolina
277125;
Harvard School of Public
Health, Boston, Massachusetts 021156;
Rush-Presbyterian-St. Luke's Medical Center, Chicago,
Illinois 606127;
Baylor College of
Medicine, Houston, Texas 770308;
University of Puerto Rico School of Medicine, San Juan, Puerto
Rico 00936-50679;
UMD-New Jersey
Medical School, Newark, New Jersey 0710310;
Mount Sinai Medical Center, New York, New York
1002911; and
University of
Washington, Seattle, Washington 9819512
Received 13 June 1997/Returned for modification 18 August
1997/Accepted 27 October 1997
Use of a common set of human immunodeficiency virus type 1 (HIV-1)
RNA standards eliminated differences among absolute HIV-1 RNA copy
number estimates made with three commercially available assays. The
relative changes in the viral RNA levels determined by the commercial
assays were similar and were unaffected by the use of a common set of
standards.
*
Corresponding author. Mailing address: NIH/NIAID/DAIDS,
6003 Executive Blvd., Rockville, MD 20776. Phone: (301) 496-0636. Fax:
(301) 402-3171. E-mail: pr20f{at}nih.gov.
Journal of Clinical Microbiology, January 1998, p. 311-314, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jackson, J. B., Piwowar-Manning, E., Johnson-Lewis, L., Bassett, R., Demeter, L. M., Brambilla, D.
(2004). Comparison of Versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR Test for Subjects with Low Viral Load. J. Clin. Microbiol.
42: 2774-2776
[Abstract]
[Full Text]
-
Ghosh, M. K., Kuhn, L., West, J., Semrau, K., Decker, D., Thea, D. M., Aldrovandi, G. M.
(2003). Quantitation of Human Immunodeficiency Virus Type 1 in Breast Milk. J. Clin. Microbiol.
41: 2465-2470
[Abstract]
[Full Text]
-
Singer, E. J., Aronow, H. A., Lee, S.-Y., Hinkin, C. H., Lazarus, T.
(2002). Stability of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Determined with the AMPLICOR HIV-1 MONITOR Test, Version 1.5 (Ultrasensitive). J. Clin. Microbiol.
40: 3863-3864
[Abstract]
[Full Text]
-
Nachman, S. A., Lindsey, J. C., Pelton, S., Mofenson, L., McIntosh, K., Wiznia, A., Stanley, K., Yogev, R.
(2002). Growth in Human Immunodeficiency Virus-Infected Children Receiving Ritonavir-Containing Antiretroviral Therapy. Arch Pediatr Adolesc Med
156: 497-503
[Abstract]
[Full Text]
-
Nowicki, M. J., Benning, L., Bremer, J. W., Meyer, W. A. III, Hanson, C., Brambilla, D., Silver, S., Kovacs, A., the Women's Interagency HIV-1 Study Collaborative,
(2001). Longitudinal Variability of Human Immunodeficiency Virus Type 1 RNA Viral Load Measurements by Nucleic Acid Sequence-Based Amplification and NucliSens Assays in a Large Multicenter Study. J. Clin. Microbiol.
39: 3760-3763
[Abstract]
[Full Text]
-
Zanchetta, N., Nardi, G., Tocalli, L., Drago, L., Bossi, C., Pulvirenti, F. R., Galli, C., Gismondo, M. R.
(2000). Evaluation of the Abbott LCx HIV-1 RNA Quantitative, a New Assay for Quantitative Determination of Human Immunodeficiency Virus Type 1 RNA. J. Clin. Microbiol.
38: 3882-3886
[Abstract]
[Full Text]
-
Bremer, J., Nowicki, M., Beckner, S., Brambilla, D., Cronin, M., Herman, S., Kovacs, A., Reichelderfer, P.
(2000). Comparison of Two Amplification Technologies for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in the Female Genital Tract. J. Clin. Microbiol.
38: 2665-2669
[Abstract]
[Full Text]
-
Elbeik, T., Charlebois, E., Nassos, P., Kahn, J., Hecht, F. M., Yajko, D., Ng, V., Hadley, K.
(2000). Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5. J. Clin. Microbiol.
38: 1113-1120
[Abstract]
[Full Text]
-
Jagodzinski, L. L., Wiggins, D. L., McManis, J. L., Emery, S., Overbaugh, J., Robb, M., Bodrug, S., Michael, N. L.
(2000). Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests. J. Clin. Microbiol.
38: 1247-1249
[Abstract]
[Full Text]
-
Nachman, S. A., Stanley, K., Yogev, R., Pelton, S., Wiznia, A., Lee, S., Mofenson, L., Fiscus, S., Rathore, M., Jimenez, E., Borkowsky, W., Pitt, J., Smith, M. E., Wells, B., McIntosh, K., for the Pediatric AIDS Clinical Trials Group 338 S,
(2000). Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial. JAMA
283: 492-498
[Abstract]
[Full Text]
-
Kirstein, L. M., Mellors, J. W., Rinaldo, C. R. Jr., Margolick, J. B., Giorgi, J. V., Phair, J. P., Dietz, E., Gupta, P., Sherlock, C. H., Hogg, R., Montaner, J. S. G., Muñoz, A.
(1999). Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma. J. Clin. Microbiol.
37: 2428-2433
[Abstract]
[Full Text]
-
Dyer, J. R., Pilcher, C. D., Shepard, R., Schock, J., Eron, J. J., Fiscus, S. A.
(1999). Comparison of NucliSens and Roche Monitor Assays for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma. J. Clin. Microbiol.
37: 447-449
[Abstract]
[Full Text]
-
Segondy, M., Izopet, J., Pellegrin, I., Montes, B., Dumon, B., Pasquier, C., Peeters, M., Fleury, H. J. A., Puel, J., Reynes, J.
(1998). Comparison of the QUANTIPLEX HIV-1 RNA 2.0 Assay with the AMPLICOR HIV-1 MONITOR 1.0 Assay for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma of Patients Receiving Stavudine-Didanosine Combination Therapy. J. Clin. Microbiol.
36: 3392-3395
[Abstract]
[Full Text]
-
(1998). Antiretroviral Therapy and Medical Management of Pediatric HIV Infection. Pediatrics
102: 1005-1062
[Full Text]
-
Lew, J., Reichelderfer, P., Fowler, M., Bremer, J., Carrol, R., Cassol, S., Chernoff, D., Coombs, R., Cronin, M., Dickover, R., Fiscus, S., Herman, S., Jackson, B., Kornegay, J., Kovacs, A., McIntosh, K., Meyer, W., Michael, N., Mofenson, L., Moye, J., Quinn, T., Robb, M., Vahey, M., Weiser, B., Yeghiazarian, T.
(1998). Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome. J. Clin. Microbiol.
36: 1471-1479
[Full Text]